{"id":1419,"date":"2019-07-09T11:10:56","date_gmt":"2019-07-09T09:10:56","guid":{"rendered":"https:\/\/curamus-cancer.fr\/le-programme-2-cancers-immuno-hematologiques-rares\/"},"modified":"2022-10-21T09:39:31","modified_gmt":"2022-10-21T07:39:31","slug":"program-2-rare-immuno-hematological-cancers","status":"publish","type":"page","link":"https:\/\/curamus-cancer.fr\/en\/program-2-rare-immuno-hematological-cancers\/","title":{"rendered":"Program 2: Rare immuno-hematological cancers"},"content":{"rendered":"<h1>Rare immuno-hematological cancers<\/h1>\n<h2>Coordinated by le Pr. V\u00e9ronique Leblond<\/h2>\n<p><strong>Rare immuno-haematological cancers<\/strong> include <strong>paediatric leukaemia<\/strong>, <strong>cancers of immunosuppressed<\/strong> people (<strong>HIV transplant recipients<\/strong> or <strong>carriers<\/strong>) that are insufficiently studied and excluded from clinical research protocols.<\/p>\n<p>The main objectives of this programme are to :<\/p>\n<ul>\n<li>Characterize at the genomic and immuno-genomic level these rare tumors and explore the interactions of the host and tumor microenvironment.<\/li>\n<li>Develop innovative diagnostic tools predictive of the evolution.<\/li>\n<li>To set up innovative therapies and procedures for monitoring long-term effects in rare tumours in adults and children.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" class=\"alignright size-full wp-image-1119 lazyload\" data-src=\"https:\/\/curamus-cancer.fr\/wp-content\/uploads\/2019\/10\/programme2_cancer-immuno-h\u00e9mato.png\" alt=\"\" width=\"1955\" height=\"490\" data-srcset=\"https:\/\/curamus-cancer.fr\/wp-content\/uploads\/2019\/10\/programme2_cancer-immuno-h\u00e9mato.png 1955w, https:\/\/curamus-cancer.fr\/wp-content\/uploads\/2019\/10\/programme2_cancer-immuno-h\u00e9mato-300x75.png 300w, https:\/\/curamus-cancer.fr\/wp-content\/uploads\/2019\/10\/programme2_cancer-immuno-h\u00e9mato-768x192.png 768w, https:\/\/curamus-cancer.fr\/wp-content\/uploads\/2019\/10\/programme2_cancer-immuno-h\u00e9mato-1024x257.png 1024w\" data-sizes=\"(max-width: 1955px) 100vw, 1955px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 1955px; --smush-placeholder-aspect-ratio: 1955\/490;\" \/><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rare immuno-hematological cancers Coordinated by le Pr. V\u00e9ronique Leblond Rare immuno-haematological cancers include paediatric leukaemia, cancers of immunosuppressed people (HIV [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1419","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Program 2: Rare immuno-hematological cancers - Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/curamus-cancer.fr\/en\/program-2-rare-immuno-hematological-cancers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Program 2: Rare immuno-hematological cancers - Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer\" \/>\n<meta property=\"og:description\" content=\"Rare immuno-hematological cancers Coordinated by le Pr. V\u00e9ronique Leblond Rare immuno-haematological cancers include paediatric leukaemia, cancers of immunosuppressed people (HIV [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/curamus-cancer.fr\/en\/program-2-rare-immuno-hematological-cancers\/\" \/>\n<meta property=\"og:site_name\" content=\"Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cancercuramus\/\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-21T07:39:31+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/program-2-rare-immuno-hematological-cancers\\\/\",\"url\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/program-2-rare-immuno-hematological-cancers\\\/\",\"name\":\"Program 2: Rare immuno-hematological cancers - Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/#website\"},\"datePublished\":\"2019-07-09T09:10:56+00:00\",\"dateModified\":\"2022-10-21T07:39:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/program-2-rare-immuno-hematological-cancers\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/program-2-rare-immuno-hematological-cancers\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/program-2-rare-immuno-hematological-cancers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Program 2: Rare immuno-hematological cancers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/\",\"name\":\"Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer\",\"description\":\"Nous soignons et prenons soin\",\"publisher\":{\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/#organization\",\"name\":\"Siric Cancer - Curamus\",\"url\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/curamus-cancer.fr\\\/wp-content\\\/uploads\\\/2019\\\/07\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/curamus-cancer.fr\\\/wp-content\\\/uploads\\\/2019\\\/07\\\/logo.jpg\",\"width\":378,\"height\":113,\"caption\":\"Siric Cancer - Curamus\"},\"image\":{\"@id\":\"https:\\\/\\\/curamus-cancer.fr\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/cancercuramus\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Program 2: Rare immuno-hematological cancers - Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/curamus-cancer.fr\/en\/program-2-rare-immuno-hematological-cancers\/","og_locale":"en_US","og_type":"article","og_title":"Program 2: Rare immuno-hematological cancers - Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer","og_description":"Rare immuno-hematological cancers Coordinated by le Pr. V\u00e9ronique Leblond Rare immuno-haematological cancers include paediatric leukaemia, cancers of immunosuppressed people (HIV [&hellip;]","og_url":"https:\/\/curamus-cancer.fr\/en\/program-2-rare-immuno-hematological-cancers\/","og_site_name":"Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer","article_publisher":"https:\/\/www.facebook.com\/cancercuramus\/","article_modified_time":"2022-10-21T07:39:31+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/curamus-cancer.fr\/en\/program-2-rare-immuno-hematological-cancers\/","url":"https:\/\/curamus-cancer.fr\/en\/program-2-rare-immuno-hematological-cancers\/","name":"Program 2: Rare immuno-hematological cancers - Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer","isPartOf":{"@id":"https:\/\/curamus-cancer.fr\/en\/#website"},"datePublished":"2019-07-09T09:10:56+00:00","dateModified":"2022-10-21T07:39:31+00:00","breadcrumb":{"@id":"https:\/\/curamus-cancer.fr\/en\/program-2-rare-immuno-hematological-cancers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/curamus-cancer.fr\/en\/program-2-rare-immuno-hematological-cancers\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/curamus-cancer.fr\/en\/program-2-rare-immuno-hematological-cancers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/curamus-cancer.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Program 2: Rare immuno-hematological cancers"}]},{"@type":"WebSite","@id":"https:\/\/curamus-cancer.fr\/en\/#website","url":"https:\/\/curamus-cancer.fr\/en\/","name":"Siric Cancer - Curamus - Site de Recherche Int\u00e9gr\u00e9e sur le Cancer","description":"Nous soignons et prenons soin","publisher":{"@id":"https:\/\/curamus-cancer.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/curamus-cancer.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/curamus-cancer.fr\/en\/#organization","name":"Siric Cancer - Curamus","url":"https:\/\/curamus-cancer.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/curamus-cancer.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/curamus-cancer.fr\/wp-content\/uploads\/2019\/07\/logo.jpg","contentUrl":"https:\/\/curamus-cancer.fr\/wp-content\/uploads\/2019\/07\/logo.jpg","width":378,"height":113,"caption":"Siric Cancer - Curamus"},"image":{"@id":"https:\/\/curamus-cancer.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cancercuramus\/"]}]}},"_links":{"self":[{"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/pages\/1419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/comments?post=1419"}],"version-history":[{"count":0,"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/pages\/1419\/revisions"}],"wp:attachment":[{"href":"https:\/\/curamus-cancer.fr\/en\/wp-json\/wp\/v2\/media?parent=1419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}